entertainment -WSS

entertainment

author：Wikipedia 2025-09-02 09:56:58 - browse：13

A few years ago, Vijay Pande, then a professor at Stanford who was using computer science to understand biology, was deciding whether to leave full-time academic work to become a venture capitalist. He turned to Andrew Ng, another Stanford professor who had joined Google Brain and later the Chinese search firm Baidu.

“The things that we dreamed about five or 10 years ago were happening now,” Pande recalled Ng telling him. “The question was, do you want to be a part of it? Or do you want to write another paper?”

Pande decided to become a venture capitalist. The result, he told an audience at a STAT event in San Francisco last week, is that, whereas he managed about $1 million to $2 million in research as a top academic, he now works at the fabled Silicon Valley firm Andreessen Horowitz, which invests $100 million a year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： STAT's guide to the next generation of CAR

explore

WSS

H5N1 bird flu: what we're starting to learn about infection in cows

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Study: Adult vaccinations pay for themselves in societal benefits

After gene therapy, two congenitally deaf children hear for the first time

H5N1 communication has been strictly for the birds

Donald Trump's relentless attacks on special counsel Jack Smith

explore

entertainment

hotspot

Medical records are filled with copy

Colonoscopy at 40? Study finds a possible benefit

What does generative AI mean for health care? We asked experts

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Psychedelics group wrestles with new pharma identity

After gene therapy, two congenitally deaf children hear for the first time

23andMe had bad news about my health. I wish a person had delivered it

Death of patient in Alzheimer’s trial raises question of possible risks

Virginia high school admissions case could be legal follow

Software glitch causes Tandem insulin pump to shutdown, FDA warns

leisure time

Researchers on aging grapple with how to calculate biological age

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

With FDA staff opposed to Sarepta therapy, top official intervened

Sanofi strikes deal with Novavax, boosting the vaccine maker

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

entertainment

knowledge

explore

explore